The Delhi High Court has temporarily halted the supply of Zydus Lifesciences’ cancer drug Ikra amid a patent dispute with AbbVie. The decision is expected to affect patients awaiting the medication and could impact the pharmaceutical market. The court’s order is a key development in the ongoing legal battle.
The Delhi High Court has temporarily halted the supply of Zydus Lifesciences’ cancer drug Ikra amid a patent dispute with AbbVie. The decision is expected to affect patients awaiting the medication and could impact the pharmaceutical market. The court’s order is a key development in the ongoing legal battle.